June 25, 2013 at 12:55 PM EDT
Is Jazz Pharmaceuticals' Diverse Lineup The Right Prescription For Investors?
Today we're going to look at Jazz Pharmaceuticals (JAZZ), which has carved out a niche for itself with a number of drugs in its lineup. The stock was featured in a June 19 New America article. Its main product is Xyrem, which is used to treat narcolepsy. It accounted for nearly 66% of the company's sales in the first quarter.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here